christian dreger joins parexel as senior vice president parexel access and parexel consulting  business wire christian dreger joins parexel as senior vice president parexel access and parexel consulting download full size small preview thumbnail christian dreger joins parexel as senior vice president parexel access and parexel consulting photo business wire paginationprevious paginationnext christian dreger joins parexel as senior vice president parexel access and parexel consulting photo business wire full size small preview thumbnail full size small preview thumbnail september    am eastern daylight time bostonbusiness wireparexel international corporation nasdaqprxl a leading global biopharmaceutical services organization today announced the appointment of christian dreger phd as senior vice president parexel access and parexel consulting dr dreger will oversee the strategy and operational management for both businesses he will also serve on parexels business review committee the companys seniormost leadership team and assist in developing and implementing parexels strategic objectives “christian brings deep industry experience and expertise to parexel throughout his career he has held global regional and local positions in emerging and established markets and in various commercial functions and crossfunctional roles with great successes” said josef von rickenbach chairman and chief executive officer parexel “christian’s leadership strengthens our ability to deliver bestinclass commercialization market access and consulting services helping our clients deliver innovative medicines and products to patients around the globe” dr dreger joins parexel from biogen where he served as vice president and head of global commercial operations biosimilars in zug switzerland he has also held international commercial and sales positions of increasing responsibility with billiondollar pl and performance management responsibilities at cubist pharmaceuticals astrazeneca scheringplough and roche pharmaceuticals and diagnostics he started his career as a consultant with mckinsey  co in germany “parexel is recognized for its global expertise in consulting regulatory outsourcing and market access services i look forward to helping parexel achieve our growth goals and further our mission” said dr dreger “in particular i am eager to work with our clients to support their consulting needs and to help insure that they meet their market access and reimbursement goals” dr dreger holds an mba and a phd from the university of mannheim in germany and st gallen switzerland and an executive mba from northwestern universitys kellogg graduate school of management he also holds an llb from the university of hagen in germany and is a certified pharmaceutical advisor and board director from insead fontainebleau france about parexel international parexel international corporation is a leading global biopharmaceutical services company providing a broad range of expertisebased clinical research consulting medical communications and technology solutions and services to the worldwide pharmaceutical biotechnology and medical device industries committed to providing solutions that expedite timetomarket and peakmarket penetration parexel has developed significant expertise across the development and commercialization continuum from drug development and regulatory consulting to clinical pharmacology clinical trials management and reimbursement parexel informatics provides advanced technology solutions including medical imaging to facilitate the clinical development process headquartered near boston massachusetts parexel has offices in  locations in  countries around the world and had approximately 6 employees in the fourth quarter for more information about parexel international visit wwwparexelcom parexel and parexel informatics are trademarks or registered trademarks of parexel international corporation or its affiliates this release contains “forwardlooking” statements regarding future results and events for this purpose any statements contained herein that are not statements of historical fact may be deemed forwardlooking statements without limiting the foregoing the words “believes” “anticipates” “plans” “expects” “intends” “appears” “estimates” “projects” “will” “would” “could” “should” “targets” and similar expressions are also intended to identify forwardlooking statements the forwardlooking statements in this release involve a number of risks and uncertainties such factors and others are discussed in the section entitled “risk factors” of the company’s most recent annual report on form k and subsequent quarterly reports on form q filed with the securities and exchange commission which “risk factors” discussion is incorporated by reference in this press release the company specifically disclaims any obligation to update these forwardlooking statements in the future these forwardlooking statements should not be relied upon as representing the company’s estimates or views as of any date subsequent to the date of this press release contacts mediaparexel international corporationcristi barnett  0cristibarnettparexelcomorinvestorsron aldridge  ronaldridgeparexelcom release summary christian dreger joins parexel as senior vice president parexel access and parexel consulting contacts mediaparexel international corporationcristi barnett  0cristibarnettparexelcomorinvestorsron aldridge  ronaldridgeparexelcom search advanced news search advanced news search log in sign up christian dreger joins parexel as senior vice president parexel access and parexel consulting employer login post jobs job seeker login sign up search life sciences jobs search job title only radius miles km  news  news by subject  news by disease   news by date  search news get our freeindustry enewsletter email       christian dreger joins parexel prxl as senior vice president parexel access and parexel consulting tweet   am   life sciences jobs     bullet newest jobs  last  hours   bullet california jobs   bullet massachusetts jobs   bullet new jersey jobs   bullet maryland jobs   bullet washington jobs   view more jobs bostonbusiness wireparexel international corporation nasdaqprxl a leading global biopharmaceutical services organization today announced the appointment of christian dreger phd as senior vice president parexel access and parexel consulting dr dreger will oversee the strategy and operational management for both businesses he will also serve on parexels business review committee the companys seniormost leadership team and assist in developing and implementing parexels strategic objectives “christian’s leadership strengthens our ability to deliver bestinclass commercialization market access and consulting services helping our clients deliver innovative medicines and products to patients around the globe” “christian brings deep industry experience and expertise to parexel throughout his career he has held global regional and local positions in emerging and established markets and in various commercial functions and crossfunctional roles with great successes” said josef von rickenbach chairman and chief executive officer parexel “christian’s leadership strengthens our ability to deliver bestinclass commercialization market access and consulting services helping our clients deliver innovative medicines and products to patients around the globe” dr dreger joins parexel from biogen where he served as vice president and head of global commercial operations biosimilars in zug switzerland he has also held international commercial and sales positions of increasing responsibility with billiondollar pl and performance management responsibilities at cubist pharmaceuticals astrazeneca scheringplough and roche pharmaceuticals and diagnostics he started his career as a consultant with mckinsey  co in germany “parexel is recognized for its global expertise in consulting regulatory outsourcing and market access services i look forward to helping parexel achieve our growth goals and further our mission” said dr dreger “in particular i am eager to work with our clients to support their consulting needs and to help insure that they meet their market access and reimbursement goals” dr dreger holds an mba and a phd from the university of mannheim in germany and st gallen switzerland and an executive mba from northwestern universitys kellogg graduate school of management he also holds an llb from the university of hagen in germany and is a certified pharmaceutical advisor and board director from insead fontainebleau france about parexel international parexel international corporation is a leading global biopharmaceutical services company providing a broad range of expertisebased clinical research consulting medical communications and technology solutions and services to the worldwide pharmaceutical biotechnology and medical device industries committed to providing solutions that expedite timetomarket and peakmarket penetration parexel has developed significant expertise across the development and commercialization continuum from drug development and regulatory consulting to clinical pharmacology clinical trials management and reimbursement parexel informatics provides advanced technology solutions including medical imaging to facilitate the clinical development process headquartered near boston massachusetts parexel has offices in  locations in  countries around the world and had approximately 6 employees in the fourth quarter for more information about parexel international visit wwwparexelcom parexel and parexel informatics are trademarks or registered trademarks of parexel international corporation or its affiliates this release contains “forwardlooking” statements regarding future results and events for this purpose any statements contained herein that are not statements of historical fact may be deemed forwardlooking statements without limiting the foregoing the words “believes” “anticipates” “plans” “expects” “intends” “appears” “estimates” “projects” “will” “would” “could” “should” “targets” and similar expressions are also intended to identify forwardlooking statements the forwardlooking statements in this release involve a number of risks and uncertainties such factors and others are discussed in the section entitled “risk factors” of the company’s most recent annual report on form k and subsequent quarterly reports on form q filed with the securities and exchange commission which “risk factors” discussion is incorporated by reference in this press release the company specifically disclaims any obligation to update these forwardlooking statements in the future these forwardlooking statements should not be relied upon as representing the company’s estimates or views as of any date subsequent to the date of this press release read at biospacecom related news parexel prxl loses 60 million in value in one day after disclosing possible misappropriation of corporate funds the xx factor fixing biotech’s gender imbalance in the csuite parexel international prxl reports fourth quarter and fiscal year  results only behind regeneron regn epipen maker mylan myl execs are the second best paid in the industry parexel international prxl announces master services agreement with pfizer pfe a look at sir andrew wittys legacy at glaxosmithkline gsk parexel consulting releases annual analysis of fda new drug review trends martin shkreli becomes reallife avengers villain in twitter war with captain america chris evans parexel consulting thought leaders provide insights into us biosimilar development and monoclonal biosimilars in two new white papers donald trump and dr oz a match made on tv please enable javascript to view the comments powered by disqus comments powered by disqus • biospacecom • parexel consulting • parexel international   • biotechpharma  personnel                 christian dreger joins parexel as senior vice president parexel access and parexel consulting photo business wire  thestreet action alerts plus access aapjim cramers best stocks for charitable trust portfoliomost recent trade alert investing rules trading commandments real money access rm rules of investingjim cramers best stocks for  commandmentsstressed out stockscramers blog cramer mad money etfs futures markets much more banksbiotechretailtechpersonal financeretirementfinancial advisor centerhow to spendoptionsfixed incomevideo privacy policyterms of use 6 thestreet inc all rights reserved djia nasdaq sp  market data updated sign in your memberships your account account preferences alerts newsletters subscribe logout subscribe access insights and guidance from our wall street pros find the product thats right for you action alerts plus action alerts options daily swing trade income seeker quant ratings real money real money pro stocks under  top stocks trifecta stocks real money pro portfolio chairmans club compare all chatter on the street christian dreger joins parexel as senior vice president parexel access and parexel consulting photo business wire business wire sep    am edt parexel international corporation nasdaqprxl a leading global biopharmaceutical services organization today announced the appointment of christian dreger phd as senior vice president parexel access and parexel consulting dr dreger will oversee the strategy and operational management for both businesses he will also serve on parexels business review committee the companys seniormost leadership team and assist in developing and implementing parexels strategic objectives this smart news release features multimedia view the full release here httpwwwbusinesswirecomnewshomeen christian dreger joins parexel as senior vice president parexel access and parexel consulting photo business wire christian brings deep industry experience and expertise to parexel throughout his career he has held global regional and local positions in emerging and established markets and in various commercial functions and crossfunctional roles with great successes said josef von rickenbach chairman and chief executive officer parexel christians leadership strengthens our ability to deliver bestinclass commercialization market access and consulting services helping our clients deliver innovative medicines and products to patients around the globe dr dreger joins parexel from biogen where he served as vice president and head of global commercial operations biosimilars in zug switzerland he has also held international commercial and sales positions of increasing responsibility with billiondollar pl and performance management responsibilities at cubist pharmaceuticals astrazeneca scheringplough and roche pharmaceuticals and diagnostics he started his career as a consultant with mckinsey  co in germany parexel is recognized for its global expertise in consulting regulatory outsourcing and market access services i look forward to helping parexel achieve our growth goals and further our mission said dr dreger in particular i am eager to work with our clients to support their consulting needs and to help insure that they meet their market access and reimbursement goals dr dreger holds an mba and a phd from the university of mannheim in germany and st gallen switzerland and an executive mba from northwestern universitys kellogg graduate school of management he also holds an llb from the university of hagen in germany and is a certified pharmaceutical advisor and board director from insead fontainebleau france if you liked this article you might like stocks lower as crude oil slides on supply concerns stocks are lower as crude oil plummets keris alison lahiff jun   0 pm edt steep selloff pulls crude into bear market sp  and nasdaq trade lower stocks are mostly lower as crude oil plummets keris alison lahiff jun    am edt stock futures narrowly mixed as oil plunges to fresh  low futures mixed even as crude oil plummets keris alison lahiff jun    am edt parexel to be taken off market by private equity pamplona agrees to take the pharmaceutical research company off the nasdaq for  per share in a deal valuing the company at  billion jonathan braude jun    am edt trending i believe ugly would be the proper term for the selloff market recon starbucks shares are crashing go out and buy amazon falls obamacare repeal fails   things you must know before the market opens chevron stock slips as q profit falls short of estimates dont buy the hype twitter isnt dead yet att verizon prove their worth advertising partners 6 thestreet inc all rights reservedaction alerts plus is a registered trademark of thestreet inc compare brokers microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext0 about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext0 where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within 0 days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext0 personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext0 personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext0 legal privacy  cookies   microsoft dreger christian profiles  facebook facebookemail or phonepasswordforgot accountenglish usespañolfrançais franceالعربيةportuguês brasilitaliano한국어deutschहिन्दीmessengerfacebook litepeopleplacesgameslocationscelebritiesmarketplacegroupsrecipesmomentsinstagramaboutcreate adcreate pagedeveloperscareersprivacycookiesad choicestermssettingsactivity log facebook   strategisches pharmamanagement  konsequente  christian dreger  springer this website uses cookies by using our website and agreeing to our cookies policy you consent to our use of cookies in accordance with the terms of this policy read more search menu   loading your cart is empty youll find more products in the shopping cart total€ view cart login  register manage account my bookshelf manage alerts article tracking book tracking login  register america change save now 0 off books in business economics  law business  management free preview   strategisches pharmamanagement konsequente wertoptimierung des totallifecycle authors dreger christian buy this book ebook  price for usa gross buy ebook isbn  digitally watermarked drmfree included format pdf ebooks can be used on all reading devices immediate ebook download after purchase softcover  price for usa buy softcover isbn  free shipping for individuals worldwide usually dispatched within  to  business days faq policy about this book die pharmaindustrie sucht nach marktgerichteten strategischen führungsinstrumenten bio und gentechnologie ermöglichen neue chancen für die entwicklung bedeuten aber auch erhöhte kosten generikawettbewerb und globaler kostendruck verschärfen den wettbewerb in den märkten erfolgreich sind jene unternehmen die eigene projekte und produkte wertoptimierend über den gesamten lebenszyklus hinweg strategisch ausrichten und führen und dazu intern die entscheidenden instrumente und fähigkeiten entwickelt haben christian dreger erarbeitet in einem präskriptiven modell diese instrumente und bewertungsmethoden für das pharmamanagement über den totallifecycle er definiert managementprozesse mit denen kontinuierlich neue informationen eingebunden und bewertet werden die bereiche fe ethischer und otcproduktlebenszyklus werden über den totallifecycle wertsteigernd optimiert show all about the authors dr christian dreger promovierte bei prof dr gerd reber am lehrstuhl für organisation und internationales management der universität linz derzeit ist er product group manager für die molekulare diagnostik  pcr bei roche diagnostics gmbh mannheim show all table of contents  chapters relevanz der themenstellung dreger christian pages  preview buy chapter  problemstellung und grundlagen dreger christian pages 0 preview buy chapter  lebenszyklus und umweltanalyse dreger christian pages  preview buy chapter  modellentwicklung dreger christian pages  preview buy chapter  zusammenfassung und ausblick dreger christian pages  preview buy chapter  read this book on springerlink buy this book ebook  price for usa gross buy ebook isbn  digitally watermarked drmfree included format pdf ebooks can be used on all reading devices immediate ebook download after purchase softcover  price for usa buy softcover isbn  free shipping for individuals worldwide usually dispatched within  to  business days faq policy services for this book download highresolution cover facebook twitter linkedin google recommended for you bibliographic information bibliographic information book title strategisches pharmamanagement book subtitle konsequente wertoptimierung des totallifecycle authors christian dreger copyright  publisher deutscher universitätsverlag copyright holder springer fachmedien wiesbaden ebook isbn  doi  softcover isbn  edition number  number of pages xxvi  number of illustrations and tables 0 illustrations in colour topics business and management general close page  page  javascript is currently disabled this site works much better if you enable javascript in your browser business  management  springer wwwspringercom this website uses cookies by using our website and agreeing to our cookies policy you consent to our use of cookies in accordance with the terms of this policy read more search menu   loading your cart is empty youll find more products in the shopping cart total€ view cart login  register manage account my bookshelf manage alerts article tracking book tracking login  register america change business  management accounting taxation  law business ethics  corporate social responsibility business information systems business startup  entrepreneurship finance human resource management  organization innovation technology management marketing sales  service operations research strategy  leadership our services for you become an author contact us stay informed social media continued growth in impact factors for springer journals find out about high impact journals and first time ifs  in your subject or subdiscipline read more change the world one article at a time find 0 groundbreaking articles across all disciplines nominated by our editorsinchief  read more tweets by springernomics business  management on these pages you will find springer’s journals books and ebooks in all areas of business and management serving researchers professionals lecturers and students we publish many of the most prestigious journals in business and management including a number of fully open access journals our book and ebook portfolio comprises major reference works textbooks and monographs from the world’s most distinguished authors wellknown publications include springer texts in business and economics the encyclopedia of operations research and management science and the journal of the academy of marketing science in thissubject area more than0 books more than journals more than series featured journals see all asia pacific journal of management small business economics journal of business economics journal of scheduling electronic commerce research management review quarterly journal of the academy of marketing science management international review networks and spatial economics business research the journal of technology transfer or spectrum review of accounting studies flexible services and manufacturing journal review of managerial science featured books see all enhancing employee engagement whittington jl et al  format ebook hardcover from  values cockpits glauner f  format ebook hardcover from  the palgrave handbook of leadership in transforming asia muenjohn n et al eds  format ebook hardcover from  handbook of marketing decision models wierenga b et al eds  format ebook hardcover from 6 featured textbooks see all handel und wettbewerb auf globalen märkten morasch k et al  format ebook softcover from  identitybased brand management burmann c et al  format ebook softcover from  linear and nonlinear optimization cottle rw et al  format ebook hardcover from  strategic marketing cases in emerging markets adhikari a et al eds  format ebook hardcover from  featured book series see all quintessence series springer texts in business and economics india studies in business and economics management for professionals mir series in international business advances in japanese business and economics contributions to management science springer proceedings in business and economics springerbriefs in business javascript is currently disabled this site works much better if you enable javascript in your browser christian dreger parexel international corp profile  biography  bloomberg feedback christian dreger senior vpparexel access  parexel consulting parexel international corp career history senior vpparexel access  parexel consulting parexel intl corp present website wwwparexelcom corporate information address  west street waltham ma 0 united states phone  fax 0 web url wwwparexelcom from the web sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data christian dreger phd  parexel josef h von rickenbachmark a goldberg mdroland andersson phddouglas a battchristian dreger phdxavier flinoisdavid j godwinmichelle grahamsimon harfordsy pretorius mdgadi saaronyjoshua schultz christian dreger phd senior vice president parexel access and parexel consulting christian dreger is senior vice president parexel access and parexel consulting  in this role he is responsible for the strategic direction and operations for two global business segments  parexel access delivers services that identify generate evaluate and communicate the evidence of product value to help accelerate time to market derisk reimbursement and market access process and improve commercial success opportunity  parexel consulting delivers technical expertise and guidance as well as operational support in areas such as integrated product development regulatory compliance and risk management and regulatory outsourcing christian has held global regional and local roles in emerging and established markets and in various commercial functions and crossfunctional capacities with billiondollar pl and performance management responsibilities  he served as vice president and head of global commercial operations biosimilars with biogen in zug switzerland  prior to that he worked as regional vice president europe at cubist pharmaceutical in zurich  christian has also held international commercial and sales positions at astrazeneca scheringplough and roche pharmaceuticals  he started his career as a consultant with mckinsey  co in germany christian holds an mba and phd from the university of mannheim in germany and st gallen switzerland and an executive mba from the kellogg school of management at northwestern university  he also holds an llb from the university of hagen in germany and is a certified pharmaceutical advisor and board director from insead fontainebleau france  key offeringskey materials key offerings key materials show more show more make christian dreger phd part of your solution management team products and services josef h von rickenbachmark a goldberg mdroland andersson phddouglas a battchristian dreger phdxavier flinoisdavid j godwinmichelle grahamsimon harfordsy pretorius mdgadi saaronyjoshua schultz related content christian dreger joins parexel as senior vice president parexel access and parexel consulting  parexel archive6 christian dreger joins parexel as senior vice president parexel access and parexel consulting boston september  — parexel international corporation nasdaq prxl a leading global biopharmaceutical services organization today announced the appointment of christian dreger phd as senior vice president parexel access and parexel consulting  dr dreger will oversee the strategy and operational management for both businesses  he will also serve on parexels business review committee the companys seniormost leadership team and assist in developing and implementing parexels strategic objectives “christian brings deep industry experience and expertise to parexel  throughout his career he has held global regional and local positions in emerging and established markets and in various commercial functions and crossfunctional roles with great successes” said josef von rickenbach chairman and chief executive officer parexel  “christian’s leadership strengthens our ability to deliver bestinclass commercialization market access and consulting services helping our clients deliver innovative medicines and products to patients around the globe” dr dreger joins parexel from biogen where he served as vice president and head of global commercial operations biosimilars in zug switzerland  he has also held international commercial and sales positions of increasing responsibility with billiondollar pl and performance management responsibilities at cubist pharmaceuticals astrazeneca scheringplough and roche pharmaceuticals and diagnostics  he started his career as a consultant with mckinsey  co in germany “parexel is recognized for its global expertise in consulting regulatory outsourcing and market access services  i look forward to helping parexel achieve our growth goals and further our mission” said dr dreger “in particular i am eager to work with our clients to support their consulting needs and to help insure that they meet their market access and reimbursement goals” dr dreger holds an mba and a phd from the university of mannheim in germany and st gallen switzerland and an executive mba from northwestern universitys kellogg graduate school of management he also holds an llb from the university of hagen in germany and is a certified pharmaceutical advisor and board director from insead fontainebleau france about parexel international parexel international corporation is a leading global biopharmaceutical services company providing a broad range of expertisebased clinical research consulting medical communications and technology solutions and services to the worldwide pharmaceutical biotechnology and medical device industries committed to providing solutions that expedite timetomarket and peakmarket penetration parexel has developed significant expertise across the development and commercialization continuum from drug development and regulatory consulting to clinical pharmacology clinical trials management and reimbursement parexel informatics provides advanced technology solutions including medical imaging to facilitate the clinical development process headquartered near boston massachusetts parexel has offices in  locations in  countries around the world and had approximately 6 employees in the fourth quarter  for more information about parexel international visit wwwparexelcom parexel and parexel informatics are trademarks or registered trademarks of parexel international corporation or its affiliates this release contains “forwardlooking” statements regarding future results and events for this purpose any statements contained herein that are not statements of historical fact may be deemed forwardlooking statements without limiting the foregoing the words “believes” “anticipates” “plans” “expects” “intends” “appears” “estimates” “projects” “will” “would” “could” “should”  “targets” and similar expressions are also intended to identify forwardlooking statements the forwardlooking statements in this release involve a number of risks and uncertainties such factors and others are discussed in the section entitled “risk factors” of the company’s most recent annual report on form k and subsequent quarterly reports on form q filed with the securities and exchange commission which “risk factors” discussion is incorporated by reference in this press release the company specifically disclaims any obligation to update these forwardlooking statements in the future these forwardlooking statements should not be relied upon as representing the company’s estimates or views as of any date subsequent to the date of this press release     make part of your solution  products and services parexel international to present at jp morgan healthcare conferenceparexel announces execution of definitive agreement to acquire health advancesoptum and parexel to accelerate drug development reimbursement and market access with ehrfueled clinical research and hybrid studiesparexel international reports second quarter fiscal year  resultsparexel launches expanded genomic research servicesparexel named a flexjobs top  company to watch for telecommuting jobs in parexel international to present at barclay’s global healthcare conferenceparexel named to the  forbes america’s best employers listparexel international announces date of third quarter fiscal year  earnings release and conference callparexel and emc form alliance to provide cloudbased document and regulatory information management servicesparexel international to present at deutsche bank healthcare conferenceparexel international reports third quarter fiscal year  resultsparexel international to present at ubs healthcare conferenceparexel international to present at goldman sach global healthcare conference and jefferies healthcare conferenceparexel named company of the year for the pharmaceuticals industry with a gold stevie from the american business awardsparexel announces master services agreement with pfizerparexel invites public to listen to live webcast of investor day presentations on june 0parexel experts to discuss key drug development insights at dia parexel international outlines growth strategy and updates financial guidance at investor dayparexel international announces date of fourth quarter and fiscal year  earnings release and conference callparexel appoints four executives to senior leadership teamparexel international reports fourth quarter and fiscal year  resultsparexel’s head of biopharm unit named to the  pharmavoice parexel international to present at wells fargo healthcare conferencechristian dreger joins parexel as senior vice president parexel access and parexel consultingparexel announces execution of definitive agreement to acquire execupharmparexel launches active tracking service for monitoring and managing temperaturecontrolled investigational medicinal productsparexel international announces date of first quarter fiscal year  earnings release and conference callparexel international reports first quarter fiscal year  results and announces new share repurchase programparexel launches idmpfocused software and service solutionparexel international to participate in evercore isi medtools conferenceparexel international announces  million accelerated share repurchase programparexel international to present at jp morgan healthcare conference related content